Methylprednisolone Sodium Succinate from Japan
Methylprednisolone sodium succinate, a derivative salt ester of the prednisone family, serves as a potent synthetic glucocorticoid for acute inflammation management via IV administration. It qualifies for HTS 2937.29.90.30 as a structural analogue salt of prednisone used primarily as a hormone. The formulation allows for high-dose pulse therapy.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide pharmacopeial compliance (Ph
• Eur./USP); ensure cold chain validation for hygroscopic salts
• Pitfall: declaring as 'intermediate' shifts to different chapter
• Track batch genealogy for recall compliance